EFFECTS OF DIBIKOR ON MICROVASCULAR FUNCTION AND BLOOD VESSEL STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2 IN THE EARLY POSTINFARCTION PERIOD
We have studied the effect of Dibikor in the therapy of patients with chronic heart failure and diabetes mellitus type 2 in the early postinfarction period. Dibikor (1 g/day for 16 weeks) in these patients especially with spastic type of microcirculation (MC) exerted a positive effect on the characteristics of MC. There occurred a redistribution of types of MC with an increase in the proportion of normocirculatory type and a decrease in the spastic type. Research has demonstrated that Dibikor therapy improves blood vessel stiffness and endothelial cell function.